Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Allopurinol 100mg tablets
1001040C0AAAAAA
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 557,765 |
|
Allopurinol 300mg tablets
1001040C0AAABAB
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 481,554 |
|
Allopurinol 100mg/5ml oral suspension
1001040C0AAAWAW
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 357 |
|
Allopurinol 100mg/5ml oral solution
1001040C0AAAPAP
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 114 |
|
Allopurinol 300mg/5ml oral suspension
1001040C0AAAXAX
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 97 |
|
Allopurinol 300mg/5ml oral solution
1001040C0AAALAL
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 13 |
|
Allopurinol 10mg/5ml oral liquid
1001040C0AAARAR
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 150mg/5ml oral liquid
1001040C0AAANAN
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 15mg/5ml oral liquid
1001040C0AAAQAQ
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 2.5mg/5ml oral suspension
1001040C0AAAZAZ
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 200mg tablets
1001040C0AABABA
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 200mg/5ml oral liquid
1001040C0AAASAS
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 20mg/5ml oral liquid
1001040C0AAAKAK
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 25mg/5ml oral suspension
1001040C0AAAYAY
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 50mg/5ml oral liquid
1001040C0AAAMAM
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 5mg/5ml oral liquid
1001040C0AAATAT
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.